A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared
With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative
Does the drug UTR1147A help patients with ulcerative colitis?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A
compared with vedolizumab and with placebo in the treatment of participants with moderate
severe UC. This study will consist of two parts, Part A and Part B. Part A will test
induction of clinical remission and Part B will test the durability of clinical remission.
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact InformationStudy Coordinator: Reference Study ID: GA39925 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search